- Home
- MTW vs ORIC Comparison
MTW vs ORIC Comparison
Compare MTW & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTW
- ORIC
- Stock Information
- Founded
- MTW 1902
- ORIC 2014
- Country
- MTW United States
- ORIC United States
- Employees
- MTW N/A
- ORIC N/A
- Industry
- MTW Construction/Ag Equipment/Trucks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MTW Industrials
- ORIC Health Care
- Exchange
- MTW Nasdaq
- ORIC Nasdaq
- Market Cap
- MTW 350.6M
- ORIC 362.9M
- IPO Year
- MTW N/A
- ORIC 2020
- Fundamental
- Price
- MTW $10.51
- ORIC $8.17
- Analyst Decision
- MTW Sell
- ORIC Strong Buy
- Analyst Count
- MTW 5
- ORIC 8
- Target Price
- MTW $10.86
- ORIC $18.83
- AVG Volume (30 Days)
- MTW 310.1K
- ORIC 1.6M
- Earning Date
- MTW 05-06-2025
- ORIC 05-05-2025
- Dividend Yield
- MTW N/A
- ORIC N/A
- EPS Growth
- MTW 68.74
- ORIC N/A
- EPS
- MTW 1.27
- ORIC N/A
- Revenue
- MTW $2,153,800,000.00
- ORIC N/A
- Revenue This Year
- MTW $2.66
- ORIC N/A
- Revenue Next Year
- MTW $4.38
- ORIC N/A
- P/E Ratio
- MTW $8.29
- ORIC N/A
- Revenue Growth
- MTW N/A
- ORIC N/A
- 52 Week Low
- MTW $7.06
- ORIC $3.90
- 52 Week High
- MTW $13.46
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- MTW 55.70
- ORIC 72.38
- Support Level
- MTW $10.26
- ORIC $5.52
- Resistance Level
- MTW $10.95
- ORIC $8.44
- Average True Range (ATR)
- MTW 0.35
- ORIC 0.63
- MACD
- MTW -0.09
- ORIC 0.32
- Stochastic Oscillator
- MTW 16.03
- ORIC 93.11
About MTW Manitowoc Company Inc. (The)
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.